Antimicrobial Drugs and Resistance

1. Selective Toxicity and the History of Antimicrobials

An antimicrobial drug is a chemical that selectively harms a microbe with minimal damage to the host. The concept traces to Paul Ehrlich, who coined the idea of a "magic bullet" — a drug that seeks out and destroys pathogens while sparing the host. Alexander Fleming discovered penicillin in 1928 after observing that a mold contaminant inhibited nearby bacterial growth, launching the era of antibiotics (antimicrobials naturally produced by microorganisms, as opposed to fully synthetic agents). Antibacterial, antifungal, and antiviral drugs each exploit features unique to their target organism class.

2. Major Drug Targets

Antibacterials act on five main targets. (1) Cell wall synthesis — drugs such as beta-lactams block peptidoglycan assembly, weakening the wall (selective because human cells lack peptidoglycan). (2) Protein synthesis — drugs bind to the bacterial 70S ribosome, which differs from the human 80S ribosome, disrupting translation. (3) Nucleic acid synthesis — drugs interfere with bacterial DNA replication or RNA transcription. (4) Cell membrane — some agents disrupt membrane integrity. (5) Folic acid (folate) synthesis — drugs block the bacterial pathway that makes folate, a pathway humans obtain from diet rather than synthesize, providing selectivity. Antifungals typically target the fungal cell membrane component ergosterol (absent from human cells) or the fungal cell wall. Antivirals must work inside host cells and therefore target viral enzymes and processes — such as viral polymerases, proteases, or entry and uncoating — that the virus needs but the host cell does not.

3. Spectrum, Susceptibility Testing, and Resistance

Broad-spectrum drugs act against a wide range of organisms, while narrow-spectrum drugs act against a limited group; narrower agents disturb the normal microbiota less. Susceptibility is assessed with the Kirby-Bauer disk-diffusion method, in which drug-impregnated disks are placed on an inoculated plate; the zone of inhibition — the clear area around a disk where the drug prevented growth — is measured and interpreted as susceptible, intermediate, or resistant. The MIC (minimum inhibitory concentration) is the lowest drug concentration that prevents visible growth (a measure of inhibition), while the MBC (minimum bactericidal concentration) is the lowest concentration that kills — together, MIC/MBC distinguish inhibition from killing. Resistance arises by mutation and horizontal gene transfer and works through five main mechanisms: efflux pumps that expel the drug; target modification that changes the drug's binding site; enzymatic inactivation that breaks the drug down (as with beta-lactamase); reduced permeability that keeps the drug out; and biofilms, which shield cells physically and metabolically. Antimicrobial stewardship is the coordinated effort to use antimicrobials appropriately — right drug, dose, and duration — to preserve their effectiveness and slow resistance.

How it works

1. A drug is chosen based on the suspected or identified organism and its known targets.
2. The drug binds a microbial-specific target (wall, ribosome, nucleic acid, membrane, or folate pathway), inhibiting or killing the microbe while sparing host cells.
3. Susceptibility testing (Kirby-Bauer, MIC/MBC) measures how well the drug works against that organism in the laboratory.
4. If the organism is resistant, one of the resistance mechanisms — efflux, target modification, enzymatic inactivation, reduced permeability, or biofilm shielding — defeats the drug.
5. Stewardship uses the right drug, dose, and duration to maximize cure while minimizing selection for resistance.

Common confusions

Memory aids

For the five antibacterial targets, remember "W-P-N-M-F" (Wall, Protein synthesis, Nucleic acids, Membrane, Folic acid). For the five resistance mechanisms, "E-T-E-R-B" (Efflux pumps, Target modification, Enzymatic inactivation, Reduced permeability, Biofilms).

Quick review

Topic Recap

Antimicrobial drugs rely on selective toxicity to harm microbes while sparing the host, a concept rooted in Ehrlich's "magic bullet" and Fleming's discovery of penicillin. Antibacterials target the cell wall, protein synthesis, nucleic acids, the cell membrane, and folic acid synthesis; antifungals and antivirals target analogous class-specific features. Broad- versus narrow-spectrum activity, Kirby-Bauer zones of inhibition, and MIC/MBC values describe a drug's reach and potency. Resistance arises via efflux pumps, target modification, enzymatic inactivation, reduced permeability, and biofilms, and is countered by antimicrobial stewardship.

Knowledge Check

1. What is selective toxicity, and why is it essential for antimicrobial drugs?
2. Why can drugs that block peptidoglycan synthesis harm bacteria but not human cells?
3. What is the difference between MIC and MBC?
4. Name three mechanisms by which bacteria become resistant to antimicrobial drugs.
5. What is the purpose of antimicrobial stewardship?

Answers and Rationales

1. Selective toxicity is harming the microbe while sparing the host. It is essential because an antimicrobial that harmed human cells as much as microbes would be too toxic to use safely.
2. Human cells lack peptidoglycan, so drugs that block its synthesis disrupt only the bacterial cell wall, not host cells.
3. MIC is the lowest concentration that inhibits visible growth; MBC is the lowest concentration that kills. MIC reflects inhibition, MBC reflects lethality.
4. Any three of: efflux pumps, target modification, enzymatic inactivation, reduced permeability, or biofilms. Each defeats the drug by a different route — expelling it, changing its target, destroying it, blocking entry, or shielding cells.
5. To use antimicrobials appropriately (right drug, dose, and duration) so they remain effective and resistance is slowed.